We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Prospective Blood Donors Deferred by Hemoglobin Estimation Methodology

By LabMedica International staff writers
Posted on 13 Dec 2015
Print article
The Sysmex XT 2000i hematology autoanalyzer
The Sysmex XT 2000i hematology autoanalyzer (Photo courtesy of Sysmex America, Inc.)
Blood transfusion is an essential part of health care and permits increasingly complex medical and surgical interventions and dramatically increases the life expectancy and quality of life of patients with a variety of acute and chronic conditions.

In developing countries, it is believed that a large majority of donor deferral could be due to a temporal and correctable cause such as anemia which is a condition of less than normal levels of healthy red blood cells circulating in the blood stream and the severity of anemia is measured by a person’s hemoglobin level.

Medical laboratory scientists at the University of Ghana (Accra) determined anemia in prospective blood donors deferred by the copper sulphate technique of hemoglobin estimation. Venous blood samples were collected into anticoagulant tubes from the subjects who were consenting potential blood donors but failed to meet the requirement for donation due to low hemoglobin level using the copper sulphate technique. The hemoglobin levels and red cell indices were measured using an automatic hematology analyzer. A thin blood film was prepared and stained using Leishman stain and then observed under the light microscope.

A total number of 1,263 prospective blood donors presented to donate blood during the period of this study. Out of these, 1,120 (88.68%) were males and 143 (11.32%) females. A total of 538 (42.6%) involving 444 males and 94 females were deferred due to varied reasons and 114 (21.2%) of these were due to low hemoglobin (Hb) level. These were assessed for anemia using Hb and red cell indices from a Sysmex 2000i hematology autoanalyzer (Sysmex Corporation; Kobe, Japan) and morphology. Those with Hb less than 13.5 g/dL for males and Hb less than 12.0 g/dL for females were termed as anemic.

Ninety two of the 114 (80.7%) were eventually diagnosed with various forms of anemia using the standard methods of full blood count and morphology. This represented 17.1% of the total number (538) deferred and 7.3% of the total (1,263) prospective donors. Twenty two or 19.3% of those who failed the copper sulphate test were found not to be anemic. Four different types of anemia based on the red cell indices and morphology studies were found in the participants who were diagnosed with anemia. These were normocytic normochromic, normocytic hypochromic, microcytic normochromic and microcytic hypochromic.

The authors concluded that there was a high prevalence of deferral of prospective blood donors and a significant proportion of these deferred donors were as a result of low Hb levels and subsequently anemia. They suggest that people who fail the copper sulphate procedure of Hb testing should not be just sent way as deferred donors but rather be assessed for anemia and be offered advice and treatment so that if their anemia can be corrected, they are encouraged to come back to donate. The study was published on October 22, 2015, in the journal BMC Hematology.

Related Links:

University of Ghana 
Sysmex Corporation


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.